In a case with important implications for late-stage private companies, a federal magistrate judge ruled last week that investors in funds holding private company securities can bring fraud claims against the issuer of the...more
4/27/2017
/ Common Law Claims ,
Corporate Issuers ,
Indirect Purchasers ,
Initial Public Offering (IPO) ,
Intermediaries ,
Life Sciences ,
Pharmaceutical Industry ,
Private Company Shares ,
Securities Fraud ,
Securities Litigation ,
Theranos ,
Unfair Competition Law (UCL)